Astec Lifesciences (NSE:ASTEC) Debt-to-Equity : N/A (As of Dec. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Astec Lifesciences Debt-to-Equity?

Astec Lifesciences's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ₹0 Mil. Astec Lifesciences's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ₹0 Mil. Astec Lifesciences's Total Stockholders Equity for the quarter that ended in Dec. 2024 was ₹0 Mil.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Astec Lifesciences's Debt-to-Equity or its related term are showing as below:

NSE:ASTEC' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.36 Med: 0.83 Max: 1.72
Current: 1.72

During the past 13 years, the highest Debt-to-Equity Ratio of Astec Lifesciences was 1.72. The lowest was 0.36. And the median was 0.83.

NSE:ASTEC's Debt-to-Equity is ranked worse than
94.44% of 234 companies
in the Agriculture industry
Industry Median: 0.39 vs NSE:ASTEC: 1.72

Astec Lifesciences Debt-to-Equity Historical Data

The historical data trend for Astec Lifesciences's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Astec Lifesciences Debt-to-Equity Chart

Astec Lifesciences Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Debt-to-Equity

Get a 7-Day Free Trial

0.40

0.61

0.71

0.81

1.34

Astec Lifesciences Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Debt-to-Equity	Get a 7-Day Free Trial															N/A	1.34	N/A	1.72	N/A

Competitive Comparison of Astec Lifesciences's Debt-to-Equity

For the Agricultural Inputs subindustry, Astec Lifesciences's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Astec Lifesciences's Debt-to-Equity Distribution in the Agriculture Industry

For the Agriculture industry and Basic Materials sector, Astec Lifesciences's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Astec Lifesciences's Debt-to-Equity falls into.

Save Embed

;

Save Embed

;

Astec Lifesciences Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Astec Lifesciences's Debt to Equity Ratio for the fiscal year that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(2948.947	+	1990)	/	3692.871
	=	1.34

Astec Lifesciences's Debt to Equity Ratio for the quarter that ended in Dec. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	0
	=	N/A

Astec Lifesciences (NSE:ASTEC) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Astec Lifesciences Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Astec Lifesciences's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Astec Lifesciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Astec Lifesciences Ltd (NSE:ASTEC) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

533138:India

Address

Eastern Express Highway, Godrej One, 3rd Floor, Pirojshanagar, Vikhroli (East), Mumbai, MH, IND, 400 079

Website

https://www.godrejastec.com

Astec Lifesciences Ltd manufactures & distributes a wide range of Agrochemical active ingredients and pharmaceutical intermediates. The company's products include agrochemicals, such as Triazole Fungicides, Herbicides, and Insecticides. The company is also into Intermediates & Specialty chemicals. Geographically, all the operations of the firm function through India; however, its products are sold in the Indian and overseas markets. It operates in the business segment of Agrochemicals and has a business presence in India and outside India.

Astec Lifesciences Headlines

No Headlines